title: Short-term consequences of N-methyl-D-aspartate excitotoxicity in rat magnocellular nucleus basalis: effects on in vivo labelling of cholinergic neurons.
abstract: Cholinergic neurons of the basal forebrain form one of the neuron populations that are susceptible to excitotoxic injury. Whereas neuropharmacological studies have aimed at rescuing cholinergic neurons from acute excitotoxic attacks, the short-term temporal profile of excitotoxic damage to cholinergic nerve cells remains largely elusive. The effects of N-methyl-D-aspartate (NMDA) infusion on cytochemical markers of cholinergic neurons in rat magnocellular nucleus basalis were therefore determined 4, 24 and 48 h post-lesion. Additionally, the influence of excitotoxic damage on the efficacy of in vivo labelling of cholinergic neurons with carbocyanine 3-192IgG was investigated. Carbocyanine 3-192IgG was unilaterally injected in the lateral ventricle. Twenty-four hours later, NMDA (60 nM/microl) was infused in the right magnocellular nucleus basalis, while control lesions were performed contralaterally. Triple immunofluorescence labelling for carbocyanine 3-192IgG, NMDA receptor 2A and B subunits and choline-acetyltransferase (ChAT) was employed to determine temporal changes in NMDA receptor immunoreactivity on cholinergic neurons. The extent of neuronal degeneration was studied by staining with Fluoro-Jade. Moreover, changes in the numbers of ChAT or p75 low-affinity neurotrophin receptor immunoreactive neurons, and the degree of their co-labelling with carbocyanine 3-192IgG were determined in basal forebrain nuclei. The effects of NMDA-induced lesions on cortical projections of cholinergic nucleus basalis neurons were studied by acetylcholinesterase (AChE) histochemistry. Characteristic signs of cellular damage, as indicated by decreased immunoreactivity for NMDA receptors, ChAT and p75 low-affinity neurotrophin receptors, were already detected at the shortest post-lesion interval investigated. Fluoro-Jade at 4 h post-lesion only labelled the core of the excitotoxic lesion. Longer survival led to enhanced Fluoro-Jade staining, and to the decline of ChAT immunoreactivity reaching a maximum 24 h post-surgery. Significant loss of p75 low-affinity neurotrophin receptor immunoreactivity and of cortical AChE-positive projections only became apparent 48 h post-lesion. Carbocyanine 3-192IgG labelling in the ipsilateral basal forebrain exceeded that of the contralateral hemisphere at all time points investigated and progressively declined in the damaged magnocellular nucleus basalis up to 48 h after NMDA infusion. The present study indicates that excitotoxic lesion-induced alteration of cholinergic neuronal markers is a rapid and gradual process reaching its maximum 24 h post-surgery. Furthermore, in vivo labelling of cholinergic neurons may be applied to indicate neuronal survival under pathological conditions, and enable to follow their degeneration process under a variety of experimental conditions.
authors.affiliation: Department of Molecular Neurobiology, University of Groningen, Haren, The Netherlands. t.harkany@biol.rug.nl
authors.forename: T
authors.initials: T
authors.lastname: Harkany
authors.forename: J
authors.initials: J
authors.lastname: Grosche
authors.forename: J
authors.initials: J
authors.lastname: Mulder
authors.forename: K M
authors.initials: KM
authors.lastname: Horvath
authors.forename: J
authors.initials: J
authors.lastname: Keijser
authors.forename: T
authors.initials: T
authors.lastname: Hortobágyi
authors.forename: P G
authors.initials: PG
authors.lastname: Luiten
authors.forename: W
authors.initials: W
authors.lastname: Härtig
mesh_terms: D000109:Acetylcholine / Q000502:physiology; D000818:Animals; D020532:Basal Nucleus of Meynert / Q000187:drug effects* / Q000473:pathology*; D002232:Carbocyanines / Q000493:pharmacokinetics; D002795:Choline O-Acetyltransferase / Q000032:analysis / Q000378:metabolism; D018690:Excitatory Amino Acid Agonists / Q000633:toxicity*; D005452:Fluoresceins; D005456:Fluorescent Dyes / Q000493:pharmacokinetics; D007074:Immunoglobulin G; D007150:Immunohistochemistry / Q000379:methods; D007276:Injections, Intraventricular; D008297:Male; D018613:Microscopy, Confocal; D016202:N-Methylaspartate / Q000633:toxicity*; D009410:Nerve Degeneration / Q000139:chemically induced / Q000473:pathology; D009434:Neural Pathways; D009457:Neuroglia / Q000378:metabolism; D009474:Neurons / Q000737:chemistry* / Q000201:enzymology / Q000473:pathology; D009498:Neurotoxins / Q000633:toxicity; D009930:Organic Chemicals; D051381:Rats; D017208:Rats, Wistar; D020800:Receptor, Nerve Growth Factor / Q000032:analysis / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000032:analysis; D012680:Sensitivity and Specificity
chemical_list: D000109:Acetylcholine; D002232:Carbocyanines; D002795:Choline O-Acetyltransferase; D018690:Excitatory Amino Acid Agonists; D005452:Fluoresceins; D005456:Fluorescent Dyes; D007074:Immunoglobulin G; D016202:N-Methylaspartate; D009498:Neurotoxins; D009930:Organic Chemicals; D020800:Receptor, Nerve Growth Factor; D016194:Receptors, N-Methyl-D-Aspartate; C121001:NR2B NMDA receptor; C089187:cyanine dye 3; C435731:fluoro jade